Insights

Innovative Technology Platform XtalPi's integrated AI-driven platform that combines quantum physics, cloud supercomputing, robotic automation, and wet lab capabilities offers a cutting-edge solution for pharmaceutical companies seeking to accelerate drug discovery and improve success rates.

Strategic Industry Partnerships Recent collaborations with PharmaEngine, Kula Bio, Well Architected Labs, and Sinar Mas highlight XtalPi’s active engagement with leading biotech, pharmaceutical, and industrial partners, creating opportunities for joint product development and commercialization.

Rapid Market Expansion Public listing in Hong Kong and ongoing acquisitions such as Liverpool ChiroChem suggest XtalPi's aggressive growth strategy and expanding market reach, which could benefit partners looking for scalable AI-driven R&D solutions.

Financial Strength and Potential With substantial funding of $780 million and revenues exceeding $100 million, XtalPi has the financial resources to invest in new technologies and expand services, presenting options for collaborative ventures or strategic investments.

Focus on Innovation Launches The recent launch of proprietary software products XFEP and XMolGen demonstrates XtalPi's commitment to advancing drug discovery capabilities, providing fertile opportunities for partners seeking innovative tools to enhance their R&D pipelines.

XtalPi Inc. Tech Stack

XtalPi Inc. uses 8 technology products and services including Google Ads Conversion Tracking, Baidu Analytics, GROMACS, and more. Explore XtalPi Inc.'s tech stack below.

  • Google Ads Conversion Tracking
    Analytics
  • Baidu Analytics
    Analytics
  • GROMACS
    Data Management
  • Wow
    Marketing Analytics
  • HubSpot
    Marketing Automation
  • Braintree
    Payment Processing
  • Python
    Programming Languages
  • Cloudflare Bot Management
    Security

Media & News

XtalPi Inc.'s Email Address Formats

XtalPi Inc. uses at least 1 format(s):
XtalPi Inc. Email FormatsExamplePercentage
First.Last@xtalpi.comJohn.Doe@xtalpi.com
96%
Last.First@xtalpi.comDoe.John@xtalpi.com
2%
Last@xtalpi.comDoe@xtalpi.com
1%
FL@xtalpi.comJD@xtalpi.com
1%

Frequently Asked Questions

Where is XtalPi Inc.'s headquarters located?

Minus sign iconPlus sign icon
XtalPi Inc.'s main headquarters is located at 245 Main Street, 11th Floor. The company has employees across 4 continents, including AsiaNorth AmericaEurope.

What is XtalPi Inc.'s official website and social media links?

Minus sign iconPlus sign icon
XtalPi Inc.'s official website is xtalpi.com and has social profiles on LinkedInCrunchbase.

What is XtalPi Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
XtalPi Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does XtalPi Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, XtalPi Inc. has approximately 501 employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Chief Executive Officer: M. J.Cso: A. J.Chief Strategy Officer: Y. A. J.. Explore XtalPi Inc.'s employee directory with LeadIQ.

What industry does XtalPi Inc. belong to?

Minus sign iconPlus sign icon
XtalPi Inc. operates in the Biotechnology Research industry.

What technology does XtalPi Inc. use?

Minus sign iconPlus sign icon
XtalPi Inc.'s tech stack includes Google Ads Conversion TrackingBaidu AnalyticsGROMACSWowHubSpotBraintreePythonCloudflare Bot Management.

What is XtalPi Inc.'s email format?

Minus sign iconPlus sign icon
XtalPi Inc.'s email format typically follows the pattern of First.Last@xtalpi.com. Find more XtalPi Inc. email formats with LeadIQ.

How much funding has XtalPi Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, XtalPi Inc. has raised $780M in funding. The last funding round occurred on Sep 01, 2020 for $400M.

When was XtalPi Inc. founded?

Minus sign iconPlus sign icon
XtalPi Inc. was founded in 2015.

XtalPi Inc.

Biotechnology ResearchMassachusetts, United States501-1000 Employees

We are a quantum physics-based, AI-powered drug R&D company with the mission to revolutionize drug discovery and development by improving the speed, scale, novelty and success rate. With operations in both China and the U.S., we strive to deploy the best capabilities and resources available to us in each market to meet the needs of our customers and collaborators.

Beyond our team’s domain expertise and creative thinking, the key to our mission is the integrated technology platform, which combines the mutually informing and reinforcing cloud supercomputing-powered in silico tools and our wet lab with robotic automation, and enables discovery and development of innovative therapeutics at a pace and scale beyond traditional alternatives. We are among the pioneering AI-powered drug R&D companies in the world that have established a platform with an iterative feedback loop between quantum physics-based dry lab and wet lab capabilities, according to Frost & Sullivan. 

With our platform designed to improve dry lab calculations with experimental data generated by the wet lab and enhance the efficiency of the wet lab by insights derived from dry lab calculations, we believe that we are well positioned at this moment where the combination of AI, computing power, data and automation is becoming increasingly critical for pharmaceutical development.

Since our founding, we have received investments and support from world-renowned investors, and we believe this blue-chip shareholder base is a testament to our capabilities and prospects.

Section iconCompany Overview

Headquarters
245 Main Street, 11th Floor
Website
xtalpi.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
501-1000

Section iconFunding & Financials

  • $780M

    XtalPi Inc. has raised a total of $780M of funding over 4 rounds. Their latest funding round was raised on Sep 01, 2020 in the amount of $400Mas a Series D.

  • $100M$250M

    XtalPi Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $780M

    XtalPi Inc. has raised a total of $780M of funding over 4 rounds. Their latest funding round was raised on Sep 01, 2020 in the amount of $400Mas a Series D.

  • $100M$250M

    XtalPi Inc.'s revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.